Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
Novo Nordisk shares sink on medicare price negotiation fears
06:02pm, Tuesday, 17'th Sep 2024
Jared Holz, Mizuho, joins 'Fast Money' to talk how possible Medicare price negotiations are impacting Novo Nordisk shares.
Novo Nordisk A/S - share repurchase programme
09:15am, Monday, 16'th Sep 2024
Bagsværd, Denmark, 16 September 2024 – On 7 August 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Co
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
05:30am, Saturday, 14'th Sep 2024
Novo Nordisk is the leader in developing drugs in a fast-growing area. DexCom's recent drop doesn't take away from its long runway for growth.
Novo Nordisk (NVO) Outperforms Broader Market: What You Need to Know
06:51pm, Thursday, 12'th Sep 2024
Novo Nordisk (NVO) reachead $136.66 at the closing of the latest trading day, reflecting a +1.06% change compared to its last close.
NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise
04:01pm, Thursday, 12'th Sep 2024
Stocks of LLY, VKTX and GPCR, which make oral pills for obesity, rose on Wednesday in response to Novo Nordisk's positive data.
Metals, Energy, Crypto: Stocks & ETFs to Watch
03:07pm, Thursday, 12'th Sep 2024
Gold (/GC) reached another new all-time high, Tesla (TSLA) continues to drive forward in the Mag 7, and Bitcoin (/BTC) marches toward the 60k level. Mish Schneider with MarketGauge.com talks about her
Novo Nordisk Stock Rises as Oral Obesity Pill Outshines Wegovy
12:55pm, Thursday, 12'th Sep 2024
NVO stock gains 4.2% after it presents efficacy data superior to Wegovy for its new oral pill, amycretin, in an early-stage study.
Five Top Obesity Stocks to Buy and Hold Long Term
11:50am, Thursday, 12'th Sep 2024
Karl-Hendrik Tittel / Getty Images There's also Altimmune (NASDAQ:ALT), whose pemvidutide treatment led to weight loss while preserving lean mass.
Roche Setback Is Big for Eli Lilly, Novo Nordisk as Obesity Drug Battle Ramps Up
08:01am, Thursday, 12'th Sep 2024
The company's stock was falling after a report detailing side effects from its once-daily weight-loss pill.
2 Weight Loss Drug Stocks Worth Stashing Away for Years
02:40pm, Wednesday, 11'th Sep 2024
As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to the chin.
PFE or NVO: Which Is the Better Value Stock Right Now?
12:45pm, Wednesday, 11'th Sep 2024
Investors with an interest in Large Cap Pharmaceuticals stocks have likely encountered both Pfizer (PFE) and Novo Nordisk (NVO). But which of these two companies is the best option for those looking f
Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise
09:18am, Wednesday, 11'th Sep 2024
Novo Nordisk stock rose moderately Wednesday after the pharma giant said its new weight-loss drug, amycretin, outperformed Wegovy.
Novo Nordisk's New Obesity Pill Beats Wegovy In Early Trial
08:18am, Wednesday, 11'th Sep 2024
Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid competition from
Novo Nordisk Stock Rises After Study Finds Obesity Drug Safe For Kids
08:08am, Wednesday, 11'th Sep 2024
A late-stage clinical trial showed drug helped children aged 6-11 reduce their BMI.
Weight loss jabs of six-year-olds? Here's the latest clinical findings
03:32am, Wednesday, 11'th Sep 2024
A recent study has found that liraglutide, a drug approved for obesity treatment in adults and teens, is safe and effective for children as young as six when combined with diet and exercise. The rese
